Crucible · Firm report card

GELSANA THERAPEUTICS INC

CO · SBIR awardee across 2 federal programs (DoD, HHS/NIH), first award 2023.

2SBIR awards
$374,600SBIR $
2 → 0Phase I → II
$1MFollow-on federal $
2Follow-on contracts

SBIR awards by program

ProgramAwardsSBIR $Phase IPhase II
DoD 1 $74,950 1 0
HHS/NIH 1 $299,650 1 0

Mission areas

Open the interactive profile of GELSANA THERAPEUTICS INC →

Full award history, follow-on contract detail, and cross-agency comparison in the Crucible app.

Data: SBIR.gov award records + USAspending.gov prime contracts, matched by recipient name. Follow-on dollars are association, not causation — they show where this firm's later federal prime-contract dollars landed, not that SBIR work caused them. Methodology